13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 36 holding rows worth $1,728,452,370.
- Accession
- 0001831942-26-000025
- Filer
- CIK 1831942
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 36 entries on the cover page, a total value of $1,728,452,370 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,728,452,370 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 17,000,000 | $169,150,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 4,200,000 | $148,512,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 3,275,000 | $128,380,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,888,007 | $111,159,389 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 1,912,380 | $96,460,447 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 2,475,000 | $94,792,500 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,696,616 | $85,536,660 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 833,600 | $85,402,320 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 5,650,000 | $78,535,000 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 750,000 | $62,467,500 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 2,723,196 | $61,217,446 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,918,970 | $54,210,903 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 3,175,000 | $51,371,500 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 1,939,000 | $50,220,100 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 825,000 | $47,973,750 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 2,000,000 | $37,800,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 1,500,000 | $36,990,000 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 2,825,000 | $36,414,250 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 2,275,000 | $35,262,500 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,258,735 | $33,045,293 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 1,000,000 | $27,750,000 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 6,336,782 | $26,424,381 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 652,432 | $21,843,423 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,575,000 | $21,810,250 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 8,695,652 | $19,652,174 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,250,000 | $19,337,500 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 4,401,500 | $16,857,745 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 7,181,062 | $12,566,859 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 1,950,000 | $10,861,500 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 5,397,488 | $9,067,780 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 2,333,713 | $7,981,298 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 4,475,000 | $7,920,750 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 483,000 | $7,211,190 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 500,000 | $5,080,000 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 464,398 | $4,774,011 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 633,901 | $4,411,951 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-26-000025 | this filing | 2026-05-15 | acceptance time not in the bulk data set |